Matteo Lambertini: Adjuvant Endocrine Therapy in HR+ Breast Cancer
Aug 30, 2025, 17:43

Matteo Lambertini: Adjuvant Endocrine Therapy in HR+ Breast Cancer

Matteo Lambertini, Associate Professor at the University of Genova, shared a post on LinkedIn:

“Published in The Lancet Group the meta-analysis on individual data that clarifies the indications on the extension of adjuvant endocrine therapy in patients with early hormone receptor positive breast cancer… great contribution of Italian academic research GIM coordinated by the super Prof. Lucia Del Mastro of Università degli Studi di Genova, Ospedale Policlinico San Martino!”

Title: Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy

Author: Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)

Read Full Article.

Matteo Lambertini: Adjuvant Endocrine Therapy in HR+ Breast Cancer

More posts featuring Matteo Lambertini on OncoDaily.